Diabetic Gastroparesis II – the interest

• Autor(a) principal: Caldeira, A.
• Data de Publicação: 2009
• Outros Autores: Calmeiro, E., Moreno, C., Bragança, G., Gonçalves, R., Silva, R.
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://revista.spmi.pt/index.php/rpmi/article/view/1391
• topic: Diabetes mellitus; neuropatia autonómica; gastroparésia diabética; cintigrama gástrico; procinético; pacemaker gástrico; Diabetes mellitus; Autonomic Neuropathy; Diabetic Gastroparesis; Gastric Cintigram; Procinetic agent; Gastric pacemaker

Gastrointestinal (GI) function is controlled by the intrinsic nervous system (the enteric plexuses - the little digestive brain) and by the extrinsic nervous system (sympathetic and parasympathetic). Gastrointestinal tract symptoms in patients with Diabetes mellitus (DM) can affect all the digestive tract. Diagnosing autonomic nervous system (SNA) affectation, particulary in what concerns to the GI function, in patients with diabetes is a very hard task, because it is usually asymptomatic or reveals no specific symptoms.Diabetic Neuropathy prevalency is very variable depending on the series. Nevertheless the treatment itself can be complex and clinically fallible.The authors present a short revision of the theme, emphasizing the importance of the Diabetic Gastroparesis (GPD) study, so that it can help both the doctor and the patient in the choice of the most appropriate insulin scheme as well as the main point of the treatment is the rigorous glycemic control associated with a good improvement in a required diet.